Amplifon S.p.A. (AMFPF)
OTCMKTS · Delayed Price · Currency is USD
18.00
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
Amplifon Revenue
Amplifon had revenue of 592.70M EUR in the quarter ending June 30, 2025, a decrease of -1.89%. This brings the company's revenue in the last twelve months to 2.41B, up 3.83% year-over-year. In the year 2024, Amplifon had annual revenue of 2.41B with 6.60% growth.
Revenue (ttm)
2.41B EUR
Revenue Growth
+3.83%
P/S Ratio
1.43
Revenue / Employee
160.08K EUR
Employees
15,070
Market Cap
4.06B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.41B | 149.16M | 6.60% |
| Dec 31, 2023 | 2.26B | 140.96M | 6.65% |
| Dec 31, 2022 | 2.12B | 171.05M | 8.78% |
| Dec 31, 2021 | 1.95B | 444.82M | 29.59% |
| Dec 31, 2020 | 1.50B | -228.81M | -13.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| QT Imaging Holdings | 8.26M |
| Northwest Biotherapeutics | 1.09M |
Amplifon News
- 13 days ago - Significant Research Activity Led To Six New Positions - Seeking Alpha
- 6 weeks ago - Stock Picks From Seeking Alpha's August 2025 New Analysts - Seeking Alpha
- 2 months ago - Amplifon: iPhone Moment Or Contrarian Opportunity Of The Year? - Seeking Alpha
- 8 months ago - Amplifon: The Hearing Care Giant Is Ready To Restart - Seeking Alpha
- 8 months ago - Italy's Amplifon posts 2024 margin below guidance, shares drop 12% - Reuters
- 1 year ago - Amplifon: A Global Leader In Hearing Care Retailing, Initiate With A 'Buy' - Seeking Alpha
- 1 year ago - Amplifon Hearing Health Care Achieves HITRUST r2 Certification - Business Wire
- 1 year ago - Italy's Amplifon trims margin forecast after lower Q3 profit - Reuters